Use of depth filters to remove prion infectivity from plasma - derived therapeutic products and/or other biologics. Depth Filtration is a chemically inactive process and therefore does not introduce potentially toxic bi-products or alter components. More

Proprietary manufacturing process for a liquid IVIgG product - in great demand world-wide as one of the principal therapeutics obtained from blood plasma. Process delivers a low IgA content, which increases renal tolerability. More

Proprietary process to produce a freeze-dried fibrinogen therapeutic product, easily soluble. Includes two virus inactivation processes: dry heat treatment and solvent/detergent. More

Novel process for production of thrombin and thrombin preparations capable of being produced in a freeze dried form, which may be heat-treated to inactivate any viruses present. More

The invention teaches a step - charge in yielding improvement over the Cohn process, widely applicable to immunoglobulin manufacture. More

This device will greatly improve patient outcomes for those individuals requiring blood transfusions by significantly lowering the incidence of transfusion related complications, while also reducing overall costs to the patient. More